View Future GrowthS.C. Helios 過去の業績過去 基準チェック /46S.C. Heliosは、平均年間18.5%の収益成長を遂げていますが、 Basic Materials業界の収益は、年間 成長しています。収益は、平均年間1% 2.2%収益成長率で 成長しています。 S.C. Heliosの自己資本利益率は10.8%であり、純利益率は17.5%です。主要情報18.50%収益成長率17.78%EPS成長率Basic Materials 業界の成長8.23%収益成長率2.18%株主資本利益率10.80%ネット・マージン17.45%前回の決算情報31 Dec 2025最近の業績更新更新なしすべての更新を表示Recent updatesBoard Change • Apr 09No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Mar 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Mar 06S.C. Helios S.A., Annual General Meeting, Apr 06, 2026S.C. Helios S.A., Annual General Meeting, Apr 06, 2026.Board Change • Jan 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON23.60, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 15x in the Basic Materials industry in Europe. Total returns to shareholders of 18% over the past year.分析記事 • Nov 21Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance CompletelyS.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...分析記事 • Nov 12We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to RON21.00, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 15x in the Basic Materials industry in Europe.分析記事 • Oct 07S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...分析記事 • Oct 07S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 16x in the Basic Materials industry in Europe.分析記事 • Jun 12S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Board Change • May 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Apr 26Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% BounceThose holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...分析記事 • Apr 21S.C. Helios (BVB:HEAL) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 25%After last week's 25% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 17x in the Basic Materials industry in Romania. Total returns to shareholders of 122% over the past year.New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (RON23.6m market cap, or US$5.16m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).お知らせ • Mar 08S.C. Helios S.A., Annual General Meeting, Apr 08, 2025S.C. Helios S.A., Annual General Meeting, Apr 08, 2025.分析記事 • Feb 25Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% CheaperThe S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to RON21.60, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 47x in the Basic Materials industry in Romania. Total returns to shareholders of 167% over the past year.分析記事 • Dec 30S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 48x in the Basic Materials industry in Romania.Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to RON19.00, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 19x in the Basic Materials industry in Romania.分析記事 • Nov 10S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 40%After last week's 40% share price gain to RON12.50, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 19x in the Basic Materials industry in Romania.分析記事 • Nov 03S.C. Helios (BVB:HEAL) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Board Change • Oct 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Sep 03A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share PriceWith a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...Board Change • Aug 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON8.95, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 24x in the Basic Materials industry in Romania.分析記事 • May 21Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to RON6.50, the stock trades at a trailing P/E ratio of 3.5x. Average trailing P/E is 10x in the Basic Materials industry in Romania.収支内訳S.C. Helios の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BVB:HEAL 収益、費用、利益 ( )RON Millions日付収益収益G+A経費研究開発費31 Dec 253267030 Sep 253257030 Jun 253257031 Mar 253356001 Jan 253456001 Oct 243456030 Jun 243546031 Mar 243536001 Jan 243536001 Oct 233636030 Jun 233726031 Mar 233736001 Jan 233836030 Sep 223536030 Jun 223236031 Mar 223036001 Jan 222936001 Oct 213036030 Jun 213126031 Mar 212925001 Jan 212825001 Oct 202625030 Jun 202415031 Mar 202415001 Jan 202525001 Oct 192525030 Jun 192514031 Mar 192514031 Dec 182514030 Sep 182614030 Jun 182814031 Mar 182814001 Jan 182814001 Oct 172714030 Jun 172614031 Mar 172614001 Jan 172514001 Oct 162513030 Jun 162413031 Mar 162513001 Jan 162513001 Oct 152513030 Jun 1524130質の高い収益: HEALは 高品質の収益 を持っています。利益率の向上: HEALの現在の純利益率 (17.5%)は、昨年(15.6%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: HEALの収益は過去 5 年間で年間18.5%増加しました。成長の加速: HEALの過去 1 年間の収益成長率 ( 5.3% ) は、5 年間の平均 ( 年間18.5%を下回っています。収益対業界: HEALの過去 1 年間の収益成長率 ( 5.3% ) はBasic Materials業界-2.5%を上回りました。株主資本利益率高いROE: HEALの 自己資本利益率 ( 10.8% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 00:53終値2026/04/24 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋S.C. Helios S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • Apr 09No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Mar 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Mar 06S.C. Helios S.A., Annual General Meeting, Apr 06, 2026S.C. Helios S.A., Annual General Meeting, Apr 06, 2026.
Board Change • Jan 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON23.60, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 15x in the Basic Materials industry in Europe. Total returns to shareholders of 18% over the past year.
分析記事 • Nov 21Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance CompletelyS.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...
分析記事 • Nov 12We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improves as stock rises 27%After last week's 27% share price gain to RON21.00, the stock trades at a trailing P/E ratio of 5.8x. Average trailing P/E is 15x in the Basic Materials industry in Europe.
分析記事 • Oct 07S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
分析記事 • Oct 07S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improves as stock rises 23%After last week's 23% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 16x in the Basic Materials industry in Europe.
分析記事 • Jun 12S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Board Change • May 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Apr 26Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% BounceThose holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...
分析記事 • Apr 21S.C. Helios (BVB:HEAL) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 25%After last week's 25% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 17x in the Basic Materials industry in Romania. Total returns to shareholders of 122% over the past year.
New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (RON23.6m market cap, or US$5.16m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
お知らせ • Mar 08S.C. Helios S.A., Annual General Meeting, Apr 08, 2025S.C. Helios S.A., Annual General Meeting, Apr 08, 2025.
分析記事 • Feb 25Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% CheaperThe S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to RON21.60, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 47x in the Basic Materials industry in Romania. Total returns to shareholders of 167% over the past year.
分析記事 • Dec 30S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...
Valuation Update With 7 Day Price Move • Dec 06Investor sentiment improves as stock rises 30%After last week's 30% share price gain to RON20.00, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 48x in the Basic Materials industry in Romania.
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to RON19.00, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 19x in the Basic Materials industry in Romania.
分析記事 • Nov 10S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The CompanyS.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 40%After last week's 40% share price gain to RON12.50, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 19x in the Basic Materials industry in Romania.
分析記事 • Nov 03S.C. Helios (BVB:HEAL) Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Board Change • Oct 10No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Sep 03A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share PriceWith a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...
Board Change • Aug 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 28%After last week's 28% share price gain to RON8.95, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 24x in the Basic Materials industry in Romania.
分析記事 • May 21Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...
Valuation Update With 7 Day Price Move • May 15Investor sentiment deteriorates as stock falls 27%After last week's 27% share price decline to RON6.50, the stock trades at a trailing P/E ratio of 3.5x. Average trailing P/E is 10x in the Basic Materials industry in Romania.